pCDCAR1 IL13Rα2 h(ζ)(CAR-LC283)
The vector of anti-IL13Rα2 chimeric antigen receptor (CAR) is a ligand-based CAR constructed for the engineering of T cells to target human IL13Rα2. The T cells are genetically modified through transduction with a retroviral vector expressing protein of IL13(E13Y) linked to CD3ζ signaling domain. And the vector product was designed for the treatment of glioblastoma multiforme.
Targeting Cell Type
Discription of Signaling Cassetes
CD3ζ, also known as T-cell receptor zeta, which together with T-cell receptor and CD3γ, δ , ε chain, forms the TCR-CD3 complex. ζ was expressed independently from the complex. The zeta chain plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. CD3-zeta, which contains 3 ITAMs, is the most commonly used endodomain component of CARs. It transmits an activation signal to the T cell after antigen is bound. CD3-zeta may not provide a fully competent activation signal and additional co-stimulatory signaling is needed. For example, chimeric CD28 and OX40 can be used with CD3-zeta to transmit a proliferative/survival signal, or all three can be used together.
Interleukin 13 receptor subunit alpha 2
IL13RA2; Interleukin 13 receptor subunit alpha 2; CT19; IL-13R; IL13BP; CD213A2
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.